Ticagrelor Market Size to Reach USD 3.60 Billion by 2035, Fueled by Rising Cardiovascular Disease Burden and Growing Adoption of Advanced Antiplatelet Therapies – SNS Insider [Yahoo! Finan...
Dr. Reddy's Laboratories Ltd (RDY)
US:NYSE Investor Relations:
drreddys.com/investors
Company Research
Source: Yahoo! Finance
Increasing Prevalence of Acute Coronary Syndrome, Expanding Post-PCI Treatment Protocols, and Growing Healthcare Infrastructure in Emerging Economies Drive Market Growth. Austin, March 16, 2026 (GLOBE NEWSWIRE) Ticagrelor Market Size & Growth Analysis: "According to SNS Insider, The Ticagrelor Market was valued at USD 1.80 Billion in 2025 and is projected to reach USD 3.60 Billion by 2035, reflecting a compound annual growth rate (CAGR) of 7.18% from 2026 to 2035." The increasing global incidence of cardiovascular diseases, including acute coronary syndrome (ACS) and myocardial infarction, continues to be the key factor driving the market for ticagrelor. The clinical efficacy of ticagrelor in the prevention of platelet aggregation and survival has established the drug as a popular antiplatelet drug among cardiologists. The increasing number of percutaneous coronary intervention (PCI) procedures has fueled the market for antiplatelet therapies in the prevention of stent thrombos
Show less
Read more
Impact Snapshot
Event Time:
RDY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RDY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RDY alerts
High impacting Dr. Reddy's Laboratories Ltd news events
Weekly update
A roundup of the hottest topics
RDY
News
- India's Zydus, Lupin sign deal to co-market Semaglutide injections [Yahoo! Finance]Yahoo! Finance
- Strait of Hormuz standoff puts supply of America's generic drug prescriptions at risk [MSNBC.com]MSNBC.com
- India Semaglutide Patent Expiry Could Drive 50% Price Drop in Weight-Loss Drugs [Yahoo! Finance]Yahoo! Finance
- Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- Prolonged Strait of Hormuz standoff will close in on America's generic drug prescriptions [CNBC]CNBC
RDY
Earnings
- 1/22/26 - Beat
RDY
Sec Filings
- 3/13/26 - Form 6-K
- 3/12/26 - Form 6-K
- 3/12/26 - Form 6-K
- RDY's page on the SEC website